Statistics for Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer : the KEYNOTE-062 phase 3 randomized clinical trial
Total visits
| views | |
|---|---|
| Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer : the KEYNOTE-062 phase 3 randomized clinical trial | 58 |
Total visits per month
| views | |
|---|---|
| July 2024 | 1 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer The KEYNOTE-062 Phase 3 Randomized.pdf | 14 |
Top country views
| views | |
|---|---|
| United States | 43 |
| Chile | 5 |
| Sweden | 3 |
| China | 2 |
| United Kingdom | 2 |
| Israel | 1 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 36 |
| Alameda | 5 |
| Santiago | 5 |
| Åkersberga | 3 |
| Newtownabbey | 2 |
| Shanghai | 2 |
| Campbell | 1 |
| Sacramento | 1 |
| Tel Aviv | 1 |
| Zapopan | 1 |